Director Dealings

Accrol Group Holdings PLC

22 August 2023

 

22 August 2023

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Accrol Group Holdings plc

("Accrol", the "Group" or the "Company")

Director Dealings

Accrol (AIM:ACRL), the UK's leading independent tissue convertor, has been notified that Dan Wright, the Executive Chairman, and Gareth Jenkins, the Chief Executive Officer have purchased an aggregate of 185,758 ordinary shares of £0.001 each ("Ordinary Shares") at a price of 32.3 pence per Ordinary Share. Details of the dealings are included in the table below:

Director	Ordinary Shares purchased	Ordinary Shares beneficially owned	% of issued share capital
Dan Wright	92,879	12,608,422*	3.95%
Gareth Jenkins	92,879	4,515,808**	1.42%

* 10,786,972 of these shares are registered in the name of Gomrath Limited, a family investment company controlled by Dan Wright

** 3,741,346 of these shares are registered in the name of Gareth's wife Susan Jenkins

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Dan Wright
2	Reason for the notification
a)	Position/status	Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Accrol Group Holdings plc
b)	LEI	213800MC56M5G69RJ226
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of £0.001 each ISIN: GB00BZ6VT592
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 32.3 pence 92,879
d)	Aggregated information - Aggregated volume - Price	N/A - Single transaction
e)	Date of the transaction	21 August 2023
f)	Place of the transaction	London Stock Exchange, AIM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Gareth Jenkins
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Accrol Group Holdings plc
b)	LEI	213800MC56M5G69RJ226
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of £0.001 each ISIN: GB00BZ6VT592
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 32.3 pence 92,879
d)	Aggregated information - Aggregated volume - Price	N/A - Single transaction
e)	Date of the transaction	21 August 2023
f)	Place of the transaction	London Stock Exchange, AIM

For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman	Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer Richard Newman, Chief Financial Officer
Zeus (Nominated Adviser & Joint Broker)
Dan Bate / Jordan Warburton / Kieran Russell	Tel: [phone]
Dominic King	Tel: [phone]
Shore Capital Stockbrokers (Joint Broker)	Tel: [phone]
Malachy McEntyre / Mark Percy / James Thomas
Belvedere Communications Limited
Cat Valentine	Tel: [phone]
Keeley Clarke	Tel: [phone]
	[e-mail]

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which together supply c.21.5% (volume) of the UK tissue market valued at c£2.5bn at retail sales value.

For more information, please visit www.accrol.com.

 

END